Erwinia L-Asparaginase (Erwinase) Study in Patients With Acute Lymphoblastic Leukemia.

Trial Profile

Erwinia L-Asparaginase (Erwinase) Study in Patients With Acute Lymphoblastic Leukemia.

Completed
Phase of Trial: Phase II

Latest Information Update: 31 Oct 2014

At a glance

  • Drugs Asparaginase (Primary) ; Asparaginase (Primary) ; Asparaginase (Primary)
  • Indications Acute lymphoblastic leukaemia
  • Focus Adverse reactions
  • Most Recent Events

    • 18 Apr 2012 Actual patient number (33) added as reported by ClinicalTrials.gov.
    • 16 Feb 2012 Actual patient number (33) added as reported by ClinicalTrials.gov.
    • 16 Feb 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top